1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Clinical High Risk for Developing Psychosis: new trials by email Literature Review of Clinical High Risk for Developing Psychosis trials Research Report on Clinical High Risk for Developing Psychosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stratification and Treatment in Early Psychosis Study - PROMOTE Cannabidiol (CBD), Placebo - Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis | Phase 3 | Not yet recruiting | University of Oxford | 586 | 2026-12-01 | 2026-10-08 |
| Stepped Care for Youth at Risk of Psychosis Supportive therapy and CBT - Clinical High Risk for Developing Psychosis | Not applicable | Completed | University of Calgary | 61 | 2021-09-01 | 2026-09-17 |
Mental Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Cannabidiol (1) · Palliative Care (1)
University of Calgary (1) · University of Oxford (1)
Canada (2) · Austria (1) · Finland (1) · Germany (1) · Greece (1) · Italy (1) · Netherlands (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Jean M Addington, PhD (1) · Philip McGuire, PhD, MD (1)